Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Roundhill Generative AI & Technology ETF
CHAT
$1.84B
| $4.14M | ﹤0.01% |
+67,260
| New | +$3.61M |
|
|
AXIA
2327
AXIA Energia
AXIA
$24.1B
| $4.14M | ﹤0.01% |
526,477
+523,320
| +16,576% | +$3.29M |
|
2328
McGrath RentCorp
MGRC
$2.92B
| $4.13M | ﹤0.01% |
35,199
-12,577
| -26% | -$1.52M |
|
2329
Standard BioTools
LAB
$339M
| $4.13M | ﹤0.01% |
3,174,634
-131,741
| -4% | -$173K |
|
2330
Cactus
WHD
$5.12B
| $4.12M | ﹤0.01% |
104,277
-33,176
| -24% | -$1.4M |
|
2331
Rush Street Interactive
RSI
$2.9B
| $4.11M | ﹤0.01% |
200,851
-30,987
| -13% | -$584K |
|
2332
Constellium
CSTM
$3.85B
| $4.1M | ﹤0.01% |
275,266
-51,152
| -16% | -$732K |
|
2333
iShares MSCI Canada ETF
EWC
$6.16B
| $4.09M | ﹤0.01% |
80,909
-72,268
| -47% | -$3.46M |
|
2334
ICU Medical
ICUI
$4.32B
| $4.09M | ﹤0.01% |
34,065
-12,532
| -27% | -$1.59M |
|
2335
VanEck Uranium + Nuclear Energy ETF
NLR
$3.96B
| $4.09M | ﹤0.01% |
+30,120
| New | +$3.59M |
|
|
BAND
2336
Bandwidth Inc
BAND
$1.4B
| $4.07M | ﹤0.01% |
244,235
-1,844
| -0.7% | -$28.4K |
|
2337
Praxis Precision Medicines
PRAX
$8.52B
| $4.06M | ﹤0.01% |
76,637
-12,087
| -14% | -$586K |
|
2338
Clear Secure
YOU
$5.56B
| $4.06M | ﹤0.01% |
121,502
-68,524
| -36% | -$2.27M |
|
2339
Freshworks
FRSH
$3.25B
| $4.04M | ﹤0.01% |
343,492
-61,270
| -15% | -$825K |
|
2340
Fulgent Genetics
FLGT
$500M
| $4.04M | ﹤0.01% |
178,867
-18,712
| -9% | -$385K |
|
2341
CALL
Abbott
ABT
$185B
| $4.03M | ﹤0.01% |
30,100
+200
| +0.7% | +$26.3K |
|
2342
United States Oil Fund
USO
$1.91B
| $4.03M | ﹤0.01% |
54,609
-18,734
| -26% | -$1.41M |
|
2343
CALL
United Airlines
UAL
$41.7B
| $4.02M | ﹤0.01% |
+41,700
| New | +$4.01M |
|
2344
FormFactor
FORM
$8.48B
| $4.02M | ﹤0.01% |
110,449
-42,384
| -28% | -$1.36M |
|
2345
Ardelyx
ARDX
$1.23B
| $4.01M | ﹤0.01% |
728,642
-164,065
| -18% | -$891K |
|
2346
HUB Group
HUBG
$2.83B
| $4.01M | ﹤0.01% |
116,392
-24,073
| -17% | -$859K |
|
|
SEI
2347
PUT
Solaris Energy Infrastructure
SEI
$3.4B
| $4M | ﹤0.01% |
+100,000
| New | +$3.13M |
|
2348
Euronet Worldwide
EEFT
$2.8B
| $3.99M | ﹤0.01% |
45,489
-100,132
| -69% | -$9.6M |
|
|
TTAN
2349
ServiceTitan Inc
TTAN
$7.95B
| $3.99M | ﹤0.01% |
39,607
+39,499
| +36,573% | +$4.33M |
|
2350
Olin
OLN
$2.12B
| $3.99M | ﹤0.01% |
159,700
+10,348
| +7% | +$230K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.